(AYI) Acuity Brands - Overview
Stock: Lighting, Controls, Building Management, Audio Video
| Risk 5d forecast | |
|---|---|
| Volatility | 34.4% |
| Relative Tail Risk | -10.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | -24.72 |
| Character TTM | |
|---|---|
| Beta | 1.618 |
| Beta Downside | 1.981 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.72% |
| CAGR/Max DD | 0.40 |
EPS (Earnings per Share)
Revenue
Description: AYI Acuity Brands February 25, 2026
Acuity Inc. (NYSE: AYI) delivers integrated lighting, controls, and building-management solutions through two primary segments: Acuity Brands Lighting (ABL), which offers a broad portfolio of luminaires and advanced electronics under brands such as Lithonia, Holophane and ElcoLED; and Acuity Intelligent Spaces (AIS), which provides Distech Controls BMS, Q-SC audio/video platforms and related services for commercial, institutional and entertainment venues.
In FY 2024 the company generated approximately $4.1 billion in revenue, up about 6 % year-over-year, with an adjusted EPS of $2.05 and an operating margin near 12 %. ABL contributed roughly 65 % of total sales, while AIS accounted for the remaining 35 %.
Key drivers for AYI include the continued rollout of LED lighting-projected to grow at a 10 % CAGR through 2028-and accelerating demand for smart-building technologies as ESG mandates and energy-cost pressures push commercial real-estate owners toward integrated BMS solutions. Overall U.S. construction spending, a macro-economic tailwind, rose about 4 % YoY in the latest quarter, supporting demand for both lighting and control systems.
For a deeper dive into AYI’s valuation metrics, you might explore the analysis on ValueRay.
Headlines to watch out for
- Commercial construction spending dictates lighting demand
- Energy efficiency regulations boost LED adoption
- Input costs for electronic components impact margins
- Interest rate hikes slow renovation projects
- Supply chain disruptions affect product availability
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 410.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.11 > 0.02 and ΔFCF/TA -1.27 > 1.0 |
| NWC/Revenue: 18.05% < 20% (prev 33.35%; Δ -15.30% < -1%) |
| CFO/TA 0.13 > 3% & CFO 610.0m > Net Income 410.4m |
| Net Debt (534.0m) to EBITDA (677.3m): 0.79 < 3 |
| Current Ratio: 2.07 > 1.5 & < 3 |
| Outstanding Shares: last quarter (31.6m) vs 12m ago -0.75% < -2% |
| Gross Margin: 48.11% > 18% (prev 0.47%; Δ 4764 % > 0.5%) |
| Asset Turnover: 106.6% > 50% (prev 99.83%; Δ 6.73% > 0%) |
| Interest Coverage Ratio: 11.88 > 6 (EBITDA TTM 677.3m / Interest Expense TTM 46.9m) |
Altman Z'' 7.56
| A: 0.18 (Total Current Assets 1.58b - Total Current Liabilities 762.4m) / Total Assets 4.65b |
| B: 0.95 (Retained Earnings 4.40b / Total Assets 4.65b) |
| C: 0.13 (EBIT TTM 557.0m / Avg Total Assets 4.26b) |
| D: 2.33 (Book Value of Equity 4.32b / Total Liabilities 1.86b) |
| Altman-Z'' Score: 7.56 = AAA |
Beneish M -2.82
| DSRI: 0.90 (Receivables 565.3m/534.7m, Revenue 4.54b/3.86b) |
| GMI: 0.97 (GM 48.11% / 46.72%) |
| AQI: 1.39 (AQ_t 0.56 / AQ_t-1 0.41) |
| SGI: 1.18 (Revenue 4.54b / 3.86b) |
| TATA: -0.04 (NI 410.4m - CFO 610.0m) / TA 4.65b) |
| Beneish M-Score: -2.82 (Cap -4..+1) = A |
What is the price of AYI shares?
Over the past week, the price has changed by -6.84%, over one month by -16.74%, over three months by -25.96% and over the past year by +3.16%.
Is AYI a buy, sell or hold?
- StrongBuy: 3
- Buy: 2
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AYI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 389.4 | 41.4% |
| Analysts Target Price | 389.4 | 41.4% |
AYI Fundamental Data Overview March 07, 2026
P/E Forward = 14.2857
P/S = 1.9072
P/B = 3.0389
P/EG = 1.2377
Revenue TTM = 4.54b USD
EBIT TTM = 557.0m USD
EBITDA TTM = 677.3m USD
Long Term Debt = 797.0m USD (from longTermDebt, last quarter)
Short Term Debt = 25.4m USD (from shortTermDebt, last quarter)
Debt = 910.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 534.0m USD (from netDebt column, last quarter)
Enterprise Value = 9.19b USD (8.65b + Debt 910.1m - CCE 376.1m)
Interest Coverage Ratio = 11.88 (Ebit TTM 557.0m / Interest Expense TTM 46.9m)
EV/FCF = 17.19x (Enterprise Value 9.19b / FCF TTM 534.5m)
FCF Yield = 5.82% (FCF TTM 534.5m / Enterprise Value 9.19b)
FCF Margin = 11.78% (FCF TTM 534.5m / Revenue TTM 4.54b)
Net Margin = 9.04% (Net Income TTM 410.4m / Revenue TTM 4.54b)
Gross Margin = 48.11% ((Revenue TTM 4.54b - Cost of Revenue TTM 2.35b) / Revenue TTM)
Gross Margin QoQ = 48.42% (prev 48.88%)
Tobins Q-Ratio = 1.98 (Enterprise Value 9.19b / Total Assets 4.65b)
Interest Expense / Debt = 1.15% (Interest Expense 10.5m / Debt 910.1m)
Taxrate = 21.04% (32.1m / 152.6m)
NOPAT = 439.8m (EBIT 557.0m * (1 - 21.04%))
Current Ratio = 2.07 (Total Current Assets 1.58b / Total Current Liabilities 762.4m)
Debt / Equity = 0.33 (Debt 910.1m / totalStockholderEquity, last quarter 2.79b)
Debt / EBITDA = 0.79 (Net Debt 534.0m / EBITDA 677.3m)
Debt / FCF = 1.00 (Net Debt 534.0m / FCF TTM 534.5m)
Total Stockholder Equity = 2.66b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.64% (Net Income 410.4m / Total Assets 4.65b)
RoE = 15.45% (Net Income TTM 410.4m / Total Stockholder Equity 2.66b)
RoCE = 16.13% (EBIT 557.0m / Capital Employed (Equity 2.66b + L.T.Debt 797.0m))
RoIC = 12.21% (NOPAT 439.8m / Invested Capital 3.60b)
WACC = 10.84% (E(8.65b)/V(9.56b) * Re(11.88%) + D(910.1m)/V(9.56b) * Rd(1.15%) * (1-Tc(0.21)))
Discount Rate = 11.88% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.31%
[DCF] Terminal Value 69.78% ; FCFF base≈517.9m ; Y1≈556.9m ; Y5≈681.9m
[DCF] Fair Price = 229.6 (EV 7.57b - Net Debt 534.0m = Equity 7.04b / Shares 30.7m; r=10.84% [WACC]; 5y FCF grow 8.48% → 2.90% )
EPS Correlation: 77.87 | EPS CAGR: 17.40% | SUE: 0.41 | # QB: 0
Revenue Correlation: 46.06 | Revenue CAGR: 6.31% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-05-31): EPS=5.30 | Chg7d=-0.010 | Chg30d=-0.010 | Revisions Net=-3 | Analysts=7
EPS current Year (2026-08-31): EPS=19.78 | Chg7d=-0.025 | Chg30d=-0.025 | Revisions Net=-4 | Growth EPS=+9.8% | Growth Revenue=+8.9%
EPS next Year (2027-08-31): EPS=21.68 | Chg7d=-0.096 | Chg30d=-0.096 | Revisions Net=+0 | Growth EPS=+9.6% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: -0.43 (2 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 11.9% - Earnings Yield 4.7%)
[Growth] Growth Spread = -3.6% (Analyst 3.6% - Implied 7.2%)